Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. | Sci Rep | 2021 | 34697393 | PubTator, text mining | PubMed |
| Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer. | Front Oncol | 2021 | 34692482 | PubTator, text mining | PubMed |
| Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies. | Cells | 2021 | 34685678 | PubTator, text mining | PubMed |
| CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis. | Int J Mol Sci | 2021 | 34681716 | PubTator, text mining | PubMed |
| The Bioinformatics Analysis of Aldosterone-Producing Adenoma and Verification of Differentially Expressed Genes. | Int J Endocrinol | 2021 | 34675975 | PubTator, text mining | PubMed |
| Neuromedin B promotes chondrocyte differentiation of mesenchymal stromal cells via calcineurin and calcium signaling. | Cell Biosci | 2021 | 34663442 | PubTator, text mining | PubMed |
| Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer. | Aging (Albany NY) | 2021 | 34628367 | PubTator, text mining | PubMed |
| Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. | J Mol Med (Berl) | 2021 | 34623477 | PubTator, text mining | PubMed |
| A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma. | Medicine (Baltimore) | 2021 | 34622829 | PubTator, text mining | PubMed |
| Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration. | Technol Cancer Res Treat | 2021 | 34617858 | PubTator, text mining | PubMed |
| Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma. | Front Genet | 2021 | 34603375 | PubTator, text mining | PubMed |
| Blood and immune development in human fetal bone marrow and Down syndrome. | Nature | 2021 | 34588693 | PubTator, text mining | PubMed |
| MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. | BMC Cancer | 2021 | 34587931 | PubTator, text mining | PubMed |
| Elucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches. | Pharmaceuticals (Basel) | 2021 | 34577580 | PubTator, text mining | PubMed |
| The RhoGEF Trio: A Protein with a Wide Range of Functions in the Vascular Endothelium. | Int J Mol Sci | 2021 | 34576329 | PubTator, text mining | PubMed |
| Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis. | Biomedicines | 2021 | 34572451 | PubTator, text mining | PubMed |
| The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity. | Cells | 2021 | 34572031 | PubTator, text mining | PubMed |
| Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint. | Arthritis Res Ther | 2021 | 34560894 | PubTator, text mining | PubMed |
| Transcriptomic Drivers of Differentiation, Maturation, and Polyploidy in Human Extravillous Trophoblast. | Front Cell Dev Biol | 2021 | 34540826 | PubTator, text mining | PubMed |
| Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes. | ERJ Open Res | 2021 | 34527724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=28